<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04092075</url>
  </required_header>
  <id_info>
    <org_study_id>DO116551A</org_study_id>
    <nct_id>NCT04092075</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the ToothWave -12 Weeks Calculus Study</brief_title>
  <official_title>Safety and Efficacy of the Silk'n Toothbrush (ToothWave), Home Use Device for Reduction of Calculus, Gingivitis and Dental Plaque.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Home Skinovations Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Home Skinovations Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the safety and efficacy of the home-use device&#xD;
      Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of&#xD;
      plaque, gingivitis, and calculus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single blind, prospective study aimed to evaluate the safety and efficacy of the&#xD;
      Silk'n toothbrush in reduction of gingivitis, dental plaque and calculus.&#xD;
&#xD;
      The study includes a total of 168 treatment sessions, twice a day, and 5 clinic visits over a&#xD;
      period of 12 weeks.&#xD;
&#xD;
      One treatment group (Silk'n toothbrush - ToothWave) and 1 control group (an ADA approved&#xD;
      power toothbrush (PTB)) will participate in the study.&#xD;
&#xD;
      For each patient, assessment data will be collected at baseline, 4 weeks, and at 6 weeks.&#xD;
      Calculus condition will be measured after 12 weeks in addition to the other timepoints. The&#xD;
      average data sets will be calculated for each group.&#xD;
&#xD;
      Treatment is defined as a timed 2 minutes of teeth brushing in a regular manner, twice a day&#xD;
      (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard&#xD;
      fluoride toothpaste. The control group will use a regular PTB and standard fluoride&#xD;
      toothpaste.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 7, 2019</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single blind prospective study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The Outcomes Assessors will not be exposed to the type of brush the subject is using or to the group they are assigned to (treatment or control).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Calculus</measure>
    <time_frame>12 weeks</time_frame>
    <description>A reduction of calculus deposits as compared to control, as evaluated by Volpe-Manhold Index.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dental plaque</measure>
    <time_frame>6 weeks</time_frame>
    <description>A reduction in the level of dental plaque compared to control, according to Rustogi Modification of the Navy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival inflammation</measure>
    <time_frame>6 weeks</time_frame>
    <description>A reduction in the level of gingival inflammation compared to control, according to the Modified Gingival Index (MGI).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Gingivitis</condition>
  <condition>Plaque</condition>
  <condition>Calculus, Dental</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment is conducted with the ToothWave toothbrush Intervention: brushing with Radio frequency (RF)-utilizing powered toothbrush</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Regular powered toothbrush Intervention: brushing with a regular powered toothbrush with no RF</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF-utilizing powered toothbrush</intervention_name>
    <description>RF-utilizing Powered toothbrush</description>
    <arm_group_label>Treatment group</arm_group_label>
    <other_name>RF toothbrush</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control placebo with no RF</intervention_name>
    <description>Placebo control, toothbrush with no RF</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Adult subjects aged 18-70, that are in good health.&#xD;
&#xD;
          2. Subject must have:&#xD;
&#xD;
             2.1. Baseline gingivitis (MGI) score of at least 1.80. 2.2. Baseline gingival bleeding&#xD;
             (GBI) of â‰¥1 on at least 20 sites. 2.3. Dental Plaque mean score greater than 0.6&#xD;
             according to the RMNPI (Rustogi Modified Navy Plaque Index).&#xD;
&#xD;
             2.4. Total Calculus deposits greater than 9 according to the Volpe-Manhold Index.&#xD;
&#xD;
          3. Have a minimum of 20 'scorable' teeth (excluding 3rd molars).&#xD;
&#xD;
          4. The subjects should understand the information provided about the investigative nature&#xD;
             of the treatment, possible benefits and side effects. Subjects will sign the Informed&#xD;
             Consent Form.&#xD;
&#xD;
          5. The subjects should be willing to comply with the study procedure and schedule,&#xD;
             including the follow up visits.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Current or history of oral cavity cancer or oropharyngeal cancer.&#xD;
&#xD;
          2. Pacemaker or internal defibrillator, or any other active electrical implant anywhere&#xD;
             in the body.&#xD;
&#xD;
          3. Pregnant or nursing by subject report.&#xD;
&#xD;
          4. Any active condition in the oral cavity at the discretion of the investigator.&#xD;
&#xD;
          5. Any surgery in the oral cavity within 3 months prior to treatment, or before complete&#xD;
             healing.&#xD;
&#xD;
          6. Subjects that do not brush regularly.&#xD;
&#xD;
          7. Any condition that might make it unsafe for the subject to participate in this study,&#xD;
             at the discretion of the investigator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bennett T Amaechi, BDS, MS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center at San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 15, 2019</study_first_submitted>
  <study_first_submitted_qc>September 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Dental Calculus</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

